House Panel Advances Bipartisan Plan to List PFAS Chemicals on Toxics Inventory

October 11, 2019 by Dan McCue
House Panel Advances Bipartisan Plan to List PFAS Chemicals on Toxics Inventory

WASHINGTON – A House subcommittee has advanced bipartisan legislation sponsored by Rep. Antonio Delgado, D-N.Y., that would require the EPA to list a dangerous class of compounds known as PFAS chemicals on its Toxics Release Inventory.

Per- and polyfluoroalkyl substances, also known as PFAS chemicals, which are found in a number of industrial and household products, ranging from non-stick pans to firefighting foam.

A number of studies have linked PFAS chemicals to birth defects, infertility, developmental delays and some cancers.

The House Energy and Commerce Subcommittee on Environment and Climate Change endorsed The PFAS Right-to-Know Act just before the start of the congressional recess.

It would require certain manufacturers, processors, and producers to report their usage of PFAS chemicals to the EPA, which would then be publicly available in accordance with the Emergency Planning Community Right to Know Act.

“Our upstate communities of Hoosick Falls and Petersburgh continue to live with the effects of PFAS contamination, and we must understand where these chemicals are being used to identify potentially contaminated sites, hold emitters accountable, and protect our drinking water.” Delgado said.

“I am pleased to see the House Energy and Commerce Subcommittee on Environment advance this bipartisan legislation that will take important steps to ensure all Americans are protected from these harmful chemicals, and I will continue to fight to bring this legislation to the House floor for a vote,” the New York congressman added.

Section 313 of the Emergency Planning and Community Right-to-Know Act created the Toxics Release Inventory Program at the EPA.

This inventory tracks the use and management of toxic chemicals capable of threatening human health and the environment. Facilities in various industry sectors are required to report annually how much of each chemical included in the inventory is being released to the environment.

This reporting system supports informed decision-making by companies, government agencies, non-governmental organizations, and the public.

H.R. 2577, The PFAS Right-To-Know Act would create a 34th chemical class that industrial facilities with over 10 employees who exceed a certain threshold of PFAS yearly, would need to report to the EPA.

Delgado has made addressing PFAS contamination in his upstate New York district a priority since taking his seat in Congress in January.

Earlier this year, the representative urged the EPA to set maximum contaminant levels for PFAS chemicals as well as enact additional provisions to address water contamination in Upstate New York and across the country.

Instead of setting these maximum contaminant levels, the EPA only announced plans to begin doing so by the end of the year.

Last month, Delgado reiterated his request of the EPA to set a Maximum Contaminant Level for PFAS chemicals during testimony before the House Transportation and Infrastructure Committee.

A+
a-
  • Antonio Delgado
  • EPA
  • PFAS
  • Toxics Release Inventory
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top